1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineMPTP PoisoningParkinsonian DisordersParkinson Disease, Secondary1-Methyl-4-phenylpyridiniumSubstantia NigraDopamine AgentsNeurotoxinsDopamineCorpus StriatumDopaminergic NeuronsTyrosine 3-MonooxygenaseStriatonigral DegenerationParkinson DiseaseMonoamine Oxidase3,4-Dihydroxyphenylacetic AcidLevodopaSelegilineAntiparkinson AgentsPyridinium CompoundsNeuroprotective AgentsDisease Models, AnimalHomovanillic AcidGlobus PallidusSaimiriNeostriatumMice, Inbred C57BLMazindolMonoamine Oxidase InhibitorsDyskinesiasSulfonium CompoundsPyridinesNeuronsDopamine Plasma Membrane Transport ProteinsNerve DegenerationNortropanesCistancheDyskinesia, Drug-InducedMotor ActivityPutamenMacaca fascicularisClorgylineMesencephalonMacaca mulattaHerbicidesVesicular Monoamine Transport ProteinsBrainCallithrixVesicular Biogenic Amine Transport ProteinsBehavior, AnimalCaudate NucleusMicrogliaBasal GangliaDopamine AgonistsReceptors, Dopamine D3NG-Nitroarginine Methyl EsterConotoxinsChromatography, High Pressure LiquidMice, KnockoutGlial Cell Line-Derived Neurotrophic FactorRotenoneDose-Response Relationship, DrugMethyl ParathionCell DeathAutoradiographyPhenyl EthersSubthalamic Nucleusalpha-SynucleinReceptors, Dopamine D2Deep Brain StimulationPC12 CellsOxidopamineNerve Tissue ProteinsOxidative Stress